Grifols - 7 Year Stock Price History | GRFS

Historical daily share price chart and data for Grifols since 2011 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Grifols as of November 12, 2018 is 20.70.
Grifols Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 21.5341 23.1363 24.6800 17.6600 20.7000 -8.66%
2017 19.8660 15.6462 23.3963 15.6462 22.6617 45.11%
2016 14.9823 15.1822 16.5945 13.4911 15.6170 1.47%
2015 15.3596 15.9879 16.7071 13.8474 15.3913 -2.49%
2014 17.7751 16.0061 21.3736 13.7014 15.7836 -4.42%
2013 13.5099 11.6002 16.5639 11.0751 16.5136 40.71%
2012 8.2315 4.7588 11.7359 4.6381 11.7359 146.17%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.462B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $54.806B 11.74
Zoetis (ZTS) United States $45.773B 31.34
Tilray (TLRY) United States $10.152B 0.00
Neurocrine Biosciences (NBIX) United States $9.559B 2108.20
Jazz Pharmaceuticals (JAZZ) Ireland $8.781B 12.60
Ionis Pharmaceuticals (IONS) United States $7.085B 0.00
Sage Therapeutics (SAGE) United States $6.139B 0.00
Impax Laboratories (AMRX) United States $5.895B 0.00
Nektar Therapeutics (NKTR) United States $5.888B 8.44
Catalent (CTLT) United States $5.453B 22.87
Loxo Oncology (LOXO) United States $5.106B 0.00
United Therapeutics (UTHR) United States $4.986B 8.15
Taro Pharmaceutical Industries (TARO) Israel $4.078B 15.10
FibroGen (FGEN) United States $3.574B 0.00
Endo (ENDP) Ireland $3.026B 4.64
USANA Health Sciences (USNA) United States $2.867B 24.40
Madrigal Pharmaceuticals (MDGL) United States $2.840B 0.00
Heron Therapeutics (HRTX) United States $2.212B 0.00
Aerie Pharmaceuticals (AERI) United States $2.171B 0.00
Xencor (XNCR) United States $2.130B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.036B 275.11
Endocyte (ECYT) United States $1.934B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.819B 0.00
PTC Therapeutics (PTCT) United States $1.703B 0.00
Corcept Therapeutics (CORT) United States $1.502B 22.05
Enanta Pharmaceuticals (ENTA) United States $1.473B 18.01
Esperion Therapeutics (ESPR) United States $1.461B 0.00
Zogenix (ZGNX) United States $1.460B 0.00
Portola Pharmaceuticals (PTLA) United States $1.458B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.439B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.430B 0.00
TESARO (TSRO) United States $1.382B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.275B 0.00
Tricida (TCDA) United States $1.251B 0.00
TherapeuticsMD (TXMD) United States $1.173B 0.00
ImmunoGen (IMGN) United States $0.884B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.844B 0.00
Radius Health (RDUS) United States $0.715B 0.00
Karyopharm Therapeutics (KPTI) United States $0.704B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.645B 0.00
Flexion Therapeutics (FLXN) United States $0.642B 0.00
GlycoMimetics (GLYC) United States $0.573B 0.00
Collegium Pharmaceutical (COLL) United States $0.513B 0.00
Akebia Therapeutics (AKBA) United States $0.511B 0.00
ChemoCentryx (CCXI) United States $0.508B 40.20
Xeris Pharmaceuticals (XERS) United States $0.484B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.482B 0.00
Dova Pharmaceuticals (DOVA) United States $0.476B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.475B 0.00
Odonate Therapeutics (ODT) United States $0.466B 0.00
OptiNose (OPTN) United States $0.448B 0.00
Dermira (DERM) United States $0.445B 0.00
ArQule (ARQL) United States $0.435B 0.00
Aquestive Therapeutics (AQST) United States $0.424B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.423B 24.88
Zafgen (ZFGN) United States $0.419B 0.00
Siga Technologies (SIGA) United States $0.405B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.399B 0.00
Forty Seven (FTSV) United States $0.397B 0.00
Mast Therapeutics (SVRA) United States $0.382B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.378B 0.00
Concert Pharmaceuticals (CNCE) United States $0.376B 0.00
Minerva Neurosciences (NERV) United States $0.371B 0.00
Depomed (ASRT) United States $0.347B 12.93
Aclaris Therapeutics (ACRS) United States $0.329B 0.00
Tapimmune (MRKR) United States $0.325B 0.00
Aratana Therapeutics (PETX) United States $0.324B 0.00
KalVista Pharmaceuticals (KALV) United States $0.323B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.308B 0.00
CASI Pharmaceuticals (CASI) United States $0.297B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.296B 0.00
Translate Bio (TBIO) United States $0.293B 0.00
Majesco Entertainment (PTE) United States $0.288B 0.00
ElectroCore (ECOR) United States $0.267B 0.00
IMV INC (IMV) Canada $0.256B 0.00
Affimed (AFMD) Germany $0.253B 0.00
Opexa Therapeutics (ACER) United States $0.242B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.240B 0.00
MEI Pharma (MEIP) United States $0.233B 0.00
Ocular Therapeutix (OCUL) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.221B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.215B 0.00
Lannett Co Inc (LCI) United States $0.209B 1.82
Tyme Technologies (TYME) United States $0.208B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.207B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.203B 0.00
Neon Therapeutics (NTGN) United States $0.202B 0.00
Galectin Therapeutics (GALT) United States $0.196B 0.00
Ardelyx (ARDX) United States $0.189B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.189B 0.00
Calithera Biosciences (CALA) United States $0.185B 0.00
Redhill Biopharma (RDHL) Israel $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 0.00
ContraFect (CFRX) United States $0.174B 0.00
Molecular Templates (MTEM) United States $0.162B 0.00
Recro Pharma (REPH) United States $0.158B 0.00
Jounce Therapeutics (JNCE) United States $0.157B 0.00
Melinta Therapeutics (MLNT) United States $0.156B 0.00
Champions Oncology (CSBR) United States $0.154B 0.00
MediWound (MDWD) Israel $0.153B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.149B 0.00
DURECT (DRRX) United States $0.147B 0.00
Adherex Technologies (FENC) United States $0.145B 0.00
Infinity Pharmaceuticals (INFI) United States $0.136B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.132B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.131B 0.00
ProNAi Therapeutics (SRRA) Canada $0.123B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.115B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
Achaogen (AKAO) United States $0.104B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
CTI BioPharma (CTIC) United States $0.099B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Iterum Therapeutics (ITRM) Ireland $0.080B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
BioLineRx (BLRX) Israel $0.074B 0.00
Forward Pharma (FWP) Denmark $0.072B 0.00
Natural Alternatives (NAII) United States $0.072B 8.01
Immune Design (IMDZ) United States $0.071B 0.00
Novan (NOVN) United States $0.068B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Trillium Therapeutics (TRIL) Canada $0.049B 0.00
Capnia (SLNO) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.045B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
KemPharm (KMPH) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.037B 0.00
Heat Biologics (HTBX) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.021B 7.50
Pain Therapeutics (PTIE) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Shineco (TYHT) China $0.017B 1.72
Aradigm (ARDM) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Apricus Biosciences (APRI) United States $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00